◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › 0-9 › 1SXP

SCHOTT Pharma AG & Co. KGaA (1SXP) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-08-16

SCHOTT Pharma AG & Co. KGaA (1SXP) operates in the Medical Instruments & Supplies industry and is headquartered in Mainz, Germany with about 4,620 employees. Its market capitalization is roughly €3 billion. In the fiscal year ended 2025-09-30, 1SXP reported €986M in revenue and €146M in net income.

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Interactive charts & full statements →

1SXP Revenue & Earnings History — Annual Income Statement

Income statement	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Total Revenue	€986M	€957M	€899M	€821M	—
Gross Profit	€332M	€323M	€316M	€296M	—
Operating Income (EBIT)	€187M	€190M	€171M	€169M	—
Net Income	€146M	€150M	€152M	€125M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1SXP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	€248M	€240M	€248M	€256M	€252M	—
Gross Profit	€75M	€80M	€76M	€96M	€83M	—
Operating Income (EBIT)	€40M	€39M	€41M	€60M	€49M	—
Net Income	€31M	€33M	€34M	€46M	€38M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1SXP Free Cash Flow History

Cash flow	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Dividends Paid	(€24M)	(€23M)	(€19M)	(€12M)	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1SXP Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	—	—	€0M	€0M	—	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1SXP Balance Sheet History

Balance sheet	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Total Assets	€1.6B	€1.4B	€1.2B	€1.2B	—
Total Liabilities	€705M	€649M	€540M	€488M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1SXP viewer.

Other Companies in Medical Instruments & Supplies

CTEC · Convatec Group PLC — $4 billion
OBCK · Ottobock SE & Co. KGaA I — $4 billion
FIE · Fielmann Group AG — $3 billion
WRBY · Warby Parker Inc. — $3 billion
PLSE · Pulse Biosciences, Inc. — $3 billion
7782 · Sincere Co., LTD. — $3 billion
AFX · Carl Zeiss Meditec AG — $3 billion
7813 · Platz Co., Ltd. — $3 billion

← 1SN All “0-9” companies 1U1 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.